Inside Johnson & Johnson’s Ottava: Engineering the Future of Soft-Tissue Surgical Robotics
Executive Overview Following a landmark FDA de novo authorization, Johnson & Johnson MedTech officially unveiled its next-generation surgical platform, the...
Executive Overview Following a landmark FDA de novo authorization, Johnson & Johnson MedTech officially unveiled its next-generation surgical platform, the...
Executive Overview The landscape of modern digital surgery has experienced a profound structural evolution. Following a coveted de novo authorization...
Executive Overview The landscape of modern minimally invasive surgery underwent a paradigm shift with the official unveiling of Johnson &...